Kenneth Allen Myszkowski, Chief Financial Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 47,564 shares at $60.50 ($2.9M) on 2022-01-05, disclosed to the SEC on 2022-01-06.
Seasonal sale ($2.9M) by Chief Financial Officer — this insider has traded ARWR in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.50 | 15,908 | $962K | 32.6% |
| 2 | $62.00 | 16,528 | $1.0M | 34.8% |
| 3 | $63.17 | 3,778 | $239K | 8.1% |
| 4 | $63.17 | 3,778 | $239K | 8.1% |
| 5 | $63.95 | 3,786 | $242K | 8.2% |
| 6 | $63.95 | 3,786 |
| $242K |
| 8.2% |
| Total | $61.99 avg | 47,564 | $2.9M | 100% |
| Filing → |
| ARWR | SELL | 2024-01-08 | $885K | — | Filing → |
| ARWR | SELL | 2023-06-29 | $543K | — | Filing → |
| ARWR | SELL | 2022-12-30 | $1.2M | — | Filing → |